Literature DB >> 21239166

The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer.

C M den Hoed1, B C van Eijck, L G Capelle, H van Dekken, K Biermann, P D Siersema, E J Kuipers.   

Abstract

BACKGROUND: Helicobacter pylori is the main risk-factor for gastric cancer through a cascade from gastritis through atrophic gastritis (AG), intestinal metaplasia (IM), dysplasia (DYS) to malignancy. The presence of these lesions in the general population predicts the gastric cancer incidence in the coming decades. Prevalence data are mostly obtained from serological studies and endoscopy data in symptomatic patients. AIM: To investigate the prevalence of H. pylori infection and its related gastric changes in asymptomatic subjects.
METHODS: 383 Patients undergoing routine colonoscopy were included. All subjects underwent upper GI endoscopy and completed the Gastrointestinal Symptom Rating Scale (GSRS). Biopsies were taken from antrum and corpus.
RESULTS: H. pylori infection was present in 22%. Non-Caucasian subjects had a significantly higher H. pylori prevalence (p < 0.001). AG, IM and DYS were together found in 9.3% of subjects. Subjects with AG, IM or DYS were significantly older (p < 0.001). No differences were found with respect to gender, presence of GI symptoms as scored by GSRS, lifestyle and medication use.
CONCLUSIONS: The prevalence of premalignant gastric lesions is considerable in general Western population with increasing age as the main risk factor. One time screening for premalignant lesions at the age of 60 years is a reasonable strategy since the numbers found imply that gastric cancer will remain a prevalent disease.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21239166     DOI: 10.1016/j.ejca.2010.12.012

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  20 in total

1.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases.

Authors:  Jian-Xia Jiang; Qing Liu; Bing Zhao; Hai-Han Zhang; Huai-Ming Sang; Soyfoo-Muhammad Djaleel; Guo-Xin Zhang; Shun-Fu Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-10       Impact factor: 4.553

Review 3.  Endoscopic Upper GI Screening.

Authors:  Alanna Ebigbo; Helmut Messmann; Christoph Römmele
Journal:  Visc Med       Date:  2019-07-25

4.  Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.

Authors:  Jennifer M Yeh; Chin Hur; Zachary Ward; Deborah Schrag; Sue J Goldie
Journal:  Gut       Date:  2015-03-16       Impact factor: 23.059

5.  Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.

Authors:  Robertino M Mera; Luis E Bravo; M Constanza Camargo; Juan C Bravo; Alberto G Delgado; Judith Romero-Gallo; Maria C Yepez; José L Realpe; Barbara G Schneider; Douglas R Morgan; Richard M Peek; Pelayo Correa; Keith T Wilson; M Blanca Piazuelo
Journal:  Gut       Date:  2017-06-24       Impact factor: 23.059

6.  Precancerous histopathologic lesions of upper gastrointestinal tract among dyspeptic patients upon endoscopic evaluations.

Authors:  Ghobad Abangah; Asghar Rahmani; Mohammad Reza Hafezi-Ahmadi; Tayebeh Emami; Khairollah Asadollahi; Ali Jaafari-Haidarlo; Atefeh Moradkhani
Journal:  J Gastrointest Cancer       Date:  2016-03

7.  Molecular imaging of gastric neoplasia with near-infrared fluorescent activatable probes.

Authors:  Shengli Ding; Randall Eric Blue; Yijing Chen; Brooks Scull; Pauline Kay Lund; Douglas Morgan
Journal:  Mol Imaging       Date:  2012 Nov-Dec       Impact factor: 4.488

8.  ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis.

Authors:  He-Ling Wang; Ping-Yi Zhou; Peng Liu; Yu Zhang
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  Low yield for non-targeted biopsies of the stomach and esophagus during elective esophagogastroduodenoscopy.

Authors:  Michael K Dougherty; Phillip P Santoiemma; Andrew T Weber; David C Metz; Yu-Xiao Yang
Journal:  Endosc Int Open       Date:  2017-12-06

10.  Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery.

Authors:  Cátia Arieira; Pedro Boal Carvalho; Francisca Dias de Castro; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2019-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.